Quest for the right Drug
מיקרו קליום, כמוסות בשחרור ממושך MICRO KALIUM, PROLONGED RELEASE CAPSULES (POTASSIUM CHLORIDE)
תרופה במרשם
תרופה בסל
נרקוטיקה
ציטוטוקסיקה
צורת מתן:
פומי : PER OS
צורת מינון:
קפסולות בשחרור ממושך : CAPSULES PROLONGED RELEASE
עלון לרופא
מינוניםPosology התוויות
Indications תופעות לוואי
Adverse reactions התוויות נגד
Contraindications אינטראקציות
Interactions מינון יתר
Overdose הריון/הנקה
Pregnancy & Lactation אוכלוסיות מיוחדות
Special populations תכונות פרמקולוגיות
Pharmacological properties מידע רוקחי
Pharmaceutical particulars אזהרת שימוש
Special Warning עלון לרופא
Physicians Leaflet
Adverse reactions : תופעות לוואי
4.8 Undesirable effects Very common: ≥ 1/10 Common: ≥ 1/100, < 1/10 Uncommon: ≥ 1/1,000, < 1/100 Rare: ≥ 1/10,000, < 1/1,000 Very rare: < 1/10,000 Not known: Frequency cannot be estimated from the available data System organ class Adverse reaction Frequency Metabolic and nutritional disorders Hyperkalaemia1 Not known Nausea2 Gastrointestinal disorders Rare Flatulence2 System organ class Adverse reaction Frequency Vomiting2 Abdominal pain2 Diarrhoea2 Occlusion3 Bleeding3 Very rare Ulceration3 Perforation3 Skin and subcutaneous tissue Pruritus disorders Rash Rare Urticaria 1 Dangerous hyperkalaemia may occur in patients whose potassium excretion or distribution in the body is disrupted (see sections 4.3 and 4.4). 2 Oral intake of potassium salts may lead to those adverse reactions. The reason for this is mucous membrane irritations of the gastrointestinal tract, which can be best reduced through increased fluid intake (as possible) and by concomitantly taking the medicinal product during or after meals or taking a reduced dosage. 3 See section 4.4. For most of these patients other simultaneous factors existed, which could be associated with such unwanted reactions (e.g. delayed intestinal passage or obstruction of the gastrointestinal tract). Reporting suspected adverse reactions Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. Any suspected adverse events should be reported to the Ministry of Health according to the National Regulation by using an online form: https://sideeffects.health.gov.il/
שימוש לפי פנקס קופ''ח כללית 1994
לא צוין
תאריך הכללה מקורי בסל
לא צוין
הגבלות
לא צוין
מידע נוסף